Artwork
iconShare
 
Manage episode 517863505 series 3700095
Content provided by Dr. Amar Rewari and Dr. Anthony Paravati, Dr. Amar Rewari, and Dr. Anthony Paravati. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Dr. Amar Rewari and Dr. Anthony Paravati, Dr. Amar Rewari, and Dr. Anthony Paravati or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

One of America's largest pharmacy benefit managers (PBMs) just announced they'll stop taking rebates from drug manufacturers. The Senate's response? "Not impressed."

Why? Because rebates are just one of five profit driving "tricks" PBMs use to quietly inflate your drug costs.

In this episode, Dr. Anthony Paravati breaks down the real money flow behind prescription drug pricing, how a system designed to reduce costs does the exact opposite

You'll learn:

  • The 7-player money map that explains where every healthcare dollar really goes

  • The 5 PBM "tricks" that turn generics into goldmines

  • How "spread pricing" means employers (and ultimately you) pay huge markups on actual drug cost

  • Why regulatory capture keeps this system legal

  • And why this reform moment in Washington matters right now

If you're an employer, benefits consultant, or policymaker, this episode will change how you see pharmacy costs forever.

If you're a patient, you'll finally understand why your prescriptions keep getting more expensive.

Because every dollar diverted to middlemen is a dollar not going to care, wages, or innovation.

🎧 Listen now to understand the role PBMs have played to drive annual healthcare spend in the US to a ridiculous $4 trillion.

  continue reading

26 episodes